Recombinant RSV (Palivizumab Biosimilar) 抗体
Research Grade
适用: Human respiratory syncytial virus A
宿主: Humanized
Chimeric
unconjugated
Recombinant Antibody
-
- 抗原 See all RSV (Palivizumab Biosimilar) products
- RSV (Palivizumab Biosimilar)
- 抗体类型
- Recombinant Antibody
- 适用
- Human respiratory syncytial virus A
-
宿主
-
Humanized
- Expression System
- Mammalian cells
-
克隆类型
- Chimeric
-
标记
- This RSV (Palivizumab Biosimilar) antibody is un-conjugated
- 应用范围
- 请咨询
- 原理
- Research Grade Palivizumab Biosimilar Antibody
- 特异性
- F, Fusion glycoprotein F0, Fusion glycoprotein F2, p27, Intervening segment, Pep27, Peptide 27, Fusion glycoprotein F1
- 纯化方法
- Protein A or G purified from cell culture supernatant.
- 纯度
- >95 % by SDS-PAGE.
- 质量等级
- Research Grade
- 亚型
- IgG1, kappa
-
-
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 2.47 mg/mL
- 缓冲液
- 0.01M PBS, pH 7.4.
- 储存条件
- 4 °C,-20 °C,-80 °C
- 储存方法
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
- 有效期
- 12 months
-
- 抗原
- RSV (Palivizumab Biosimilar)
- 别名
- Palivizumab Biosimilar (RSV (Palivizumab Biosimilar) 产品)
- 物质类
- Biosimilar
- 背景
- F, Fusion glycoprotein F0, Fusion glycoprotein F2, p27, Intervening segment, Pep27, Peptide 27, Fusion glycoprotein F1
- UniProt
- P03420
- CAS-编号
- 188039-54-5
-
You are here:
